Study of a new drug for high blood pressure from aldosterone
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests a new medicine, SAL0140, for people with primary aldosteronism, a condition where the adrenal glands make too much aldosterone, causing high blood pressure. The study aims to see if the drug can lower blood pressure and improve health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with primary aldosteronism.
- Your average seated blood pressure is at least 145 mmHg (systolic).
- You are already taking blood pressure medication.
- Your potassium level is between 3.0 and 5.0 mmol/L.
- You are willing to follow study rules, including birth control if applicable.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new drug called QLS1410 for people with primary aldosteronism, a condition that causes high blood pressure due to too much aldosterone. The drug aims to lower blood pressure and improve health, potentially offering a new treatment option.
This trial looks at whether adding spironolactone to your current blood pressure medicines works better for people with primary aldosteronism (a condition where your adrenal glands make too much aldosterone, raising blood pressure). You may qualify if you have this form of high blood pressure but have declined surgery or don't have an adenoma.
This trial tests whether a treatment called SAAE can improve “ventricular remodeling,” meaning changes in the heart muscle, in people with primary aldosteronism (PA). It may help the heart work more efficiently by targeting the cause of high aldosterone levels.
This study tests whether adjusting a type of blood pressure medication (called a mineralocorticoid receptor antagonist) based on renin levels is safe and helpful for people with primary aldosteronism. It aims to find a better way to manage the condition.
This study examines how different methods of measuring hormone levels in the blood help identify primary aldosteronism (a condition causing high blood pressure). Researchers want to find the best cutoff values to identify patients who might benefit from surgery to remove part of the adrenal gland.
This trial studies people with high blood pressure caused by a hormone problem called primary aldosteronism. If you qualify, the study may help doctors learn better ways to identify and manage this specific cause of blood pressure elevation.
Hear when a new Primary Aldosteronism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.